CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding CalciMedica, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 4.26M | 3.97M | −296.0K (−6.9%) |
| Value | $15.1M | $7.49M | −$7.60M (−50.4%) |
New holders (4)
Institutions that held CalciMedica, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PVG Asset Management Corp | 30,385 | $58.0K | 0.25% |
| Cambridge Investment Research Advisors, Inc. | 23,539 | $45.0K | 0.00% |
| 180 Wealth Advisors, LLC | 16,400 | $31.3K | 0.00% |
| First Manhattan Co | 13,226 | $25.3K | 0.00% |
Sold out (3)
Institutions that held CalciMedica, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Alyeska Investment Group, L.P. | 372,256 | $1.32M |
| Russell Investments Group, Ltd. | 500 | $1.77K |
| CoreCap Advisors, LLC | 45 | $159 |